Results
3048
Every company on Simply Wall St ordered by total Snowflake score (not a Buy recommendation).
3048 companies
Aytu BioPharma
Market Cap: US$20.2m
A pharmaceutical company, focuses on commercializing novel therapeutics in the United States and internationally.
AYTU
US$2.25
7D
-4.3%
1Y
-5.9%
NovaBay Pharmaceuticals
Market Cap: US$21.7m
Does not have significant operations.
NBY
US$3.73
7D
109.6%
1Y
736.7%
Ardelyx
Market Cap: US$1.6b
Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.
ARDX
US$6.52
7D
2.5%
1Y
16.4%
Viking Therapeutics
Market Cap: US$3.0b
A clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders.
VKTX
US$26.98
7D
-0.3%
1Y
-50.2%
Evogene
Market Cap: ₪36.3m
Operates as a computational biology company in Israel, the United States, Israel, Brazil, and internationally.
EVGN
₪4.05
7D
-4.3%
1Y
-64.0%
AcouSort
Market Cap: SEK 66.7m
A technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets.
ACOU
SEK 3.15
7D
-2.2%
1Y
-79.3%
Cannonau
Market Cap: US$48.4k
Engages in the provision of cannabidiol based products.
CNNC
US$0.0002
7D
100.0%
1Y
-90.9%
Eton Pharmaceuticals
Market Cap: US$479.2m
A pharmaceutical company, focuses on developing and commercializing treatments for rare diseases.
ETON
US$17.67
7D
2.1%
1Y
285.0%
Innovotech
Market Cap: CA$10.5m
Provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally.
IOT
CA$0.21
7D
-12.5%
1Y
61.5%
Kiora Pharmaceuticals
Market Cap: US$9.4m
A clinical-stage specialty pharmaceutical company, engages in the development and commercialization of therapies for the treatment of ophthalmic diseases.
KPRX
US$2.68
7D
-3.6%
1Y
-24.3%
Adagene
Market Cap: US$100.9m
A clinical stage biotechnology company, engages in the research, development, and production of monoclonal antibody drugs for cancers in the People’s Republic of China.
ADAG
US$2.20
7D
3.3%
1Y
-15.7%
OnKure Therapeutics
Market Cap: US$36.4m
A clinical-stage biopharmaceutical company, focuses on the discovery and development of precision medicines that target biologically validated drivers of cancers.
OKUR
US$2.75
7D
0%
1Y
n/a
Lipigon Pharmaceuticals
Market Cap: SEK 104.5m
Develops drugs for lipid related diseases in Sweden.
LPGO
SEK 0.17
7D
-7.0%
1Y
-32.1%
Galmed Pharmaceuticals
Market Cap: US$7.0m
A biopharmaceutical company, focuses on the development of Aramchol for the treatment of liver diseases.
GLMD
US$1.36
7D
7.1%
1Y
-55.0%
Corvus Pharmaceuticals
Market Cap: US$427.0m
A clinical stage biopharmaceutical company, engages in the development of product candidates that precisely target proteins that are critical to immune cell maturation and function in the United States.
CRVS
US$6.16
7D
7.3%
1Y
52.9%
Elicera Therapeutics
Market Cap: SEK 338.3m
A clinical stage immuno-oncology company, develops cell and gene therapies for immune-based cancer treatments in Sweden.
ELIC
SEK 6.97
7D
-1.4%
1Y
285.1%
ImmuCell
Market Cap: US$59.0m
An animal health company, develops, manufactures, and sells products that enhance the health and productivity of dairy and beef cattle in the United States and internationally.
ICCC
US$6.33
7D
-1.1%
1Y
58.6%
CareDx
Market Cap: US$697.3m
Engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally.
CDNA
US$13.82
7D
1.2%
1Y
-49.0%
ArriVent BioPharma
Market Cap: US$791.9m
A clinical-stage biopharmaceutical company, engages in the identification, development, and commercialization of medicines for the unmet medical needs of patients with cancers.
AVBP
US$20.19
7D
5.6%
1Y
-27.9%
High Tech Pharm
Market Cap: ₩136.0b
Researches and develops, manufactures, and sells injectable carbapenem-based antibiotics worldwide.
A106190
₩12,790.00
7D
7.5%
1Y
-6.1%
Cisen Pharmaceutical
Market Cap: CN¥11.4b
Research, develops, produces, and sells drug products in China and internationally.
603367
CN¥25.21
7D
-1.0%
1Y
103.8%
Vivo Bio Tech
Market Cap: ₹777.2m
Provides drug development and discovery services to pharmaceutical and biotech companies worldwide.
511509
₹36.43
7D
-1.0%
1Y
-2.5%
Whan In PharmLtd
Market Cap: ₩160.2b
Manufactures and sells various pharmaceuticals products in South Korea.
A016580
₩10,490.00
7D
-0.9%
1Y
-19.7%
Innovent Biologics
Market Cap: HK$176.6b
A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, and internationally.
1801
HK$103.10
7D
6.5%
1Y
138.9%
C&R Research
Market Cap: ₩56.6b
n/a
A359090
₩993.00
7D
-1.6%
1Y
-12.0%
Jiangsu Jibeier Pharmaceutical
Market Cap: CN¥8.0b
A pharmaceutical company, engages in the research, development, production, and sale of chemical pharmaceutical preparations, Chinese medicine, and drugs.
688566
CN¥40.23
7D
8.1%
1Y
104.3%
Shaanxi Panlong Pharmaceutical Group Limited By Share
Market Cap: CN¥3.1b
Researches and develops, produces, and sells Chinese patent medicines in China.
002864
CN¥29.44
7D
-0.9%
1Y
23.5%
AstraZeneca Pharma India
Market Cap: ₹227.2b
A biopharmaceutical company, manufactures, markets, and trades in pharmaceutical products in India and internationally.
506820
₹9,088.15
7D
7.3%
1Y
31.7%
Innova Captab
Market Cap: ₹52.0b
An integrated pharmaceutical company, engages in the research and development, manufacture, distribution, and marketing of drugs in India and internationally.
INNOVACAP
₹908.90
7D
0.8%
1Y
20.9%
Ildong Holdings
Market Cap: ₩99.1b
Develops, manufactures, and supplies pharmaceutical products in South Korea and internationally.
A000230
₩8,780.00
7D
-4.8%
1Y
13.0%
Silco Pharmaceuticals
Market Cap: ৳1.7b
Engages in manufacturing and marketing of finished pharmaceutical products in Bangladesh and internationally.
SILCOPHL
৳16.60
7D
1.2%
1Y
-12.2%
HitGen
Market Cap: CN¥10.8b
Operates as a drug discovery research platform for small molecules and nucleic acid drugs in China and internationally.
688222
CN¥27.06
7D
4.6%
1Y
210.3%
Sino Biopharmaceutical
Market Cap: HK$159.4b
An investment holding company, operates as a research and development pharmaceutical conglomerate in the People’s Republic of China.
1177
HK$8.91
7D
9.9%
1Y
181.1%
OPC Pharmaceutical
Market Cap: ₫1.5t
Engages in the processing, manufacturing, trading, importing, and exporting of traditional, herbal, and nature-based medicines in Vietnam and internationally.
OPC
₫22,950.00
7D
-0.2%
1Y
-1.5%
Dynavax Technologies
Market Cap: US$1.2b
A commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States and internationally.
DVAX
US$10.06
7D
-0.6%
1Y
-8.8%
May & Baker Nigeria
Market Cap: ₦31.1b
May & Baker Nigeria Plc, together with its subsidiaries, manufactures, sells, and distributes human pharmaceuticals, human vaccines, and consumer products in Nigeria.
MAYBAKER
₦18.05
7D
0%
1Y
157.9%